Asset Management One Co. Ltd. Boosts Stake in HCA Healthcare, Inc. $HCA

Asset Management One Co. Ltd. lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 77,038 shares of the company’s stock after purchasing an additional 477 shares during the quarter. Asset Management One Co. Ltd.’s holdings in HCA Healthcare were worth $29,513,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Cheviot Value Management LLC bought a new position in HCA Healthcare in the 1st quarter valued at approximately $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare in the 1st quarter worth $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth $27,000. Finally, Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare in the second quarter worth about $27,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $446.58 on Friday. The firm has a 50 day simple moving average of $414.84 and a 200-day simple moving average of $381.67. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $461.56. The stock has a market cap of $104.50 billion, a price-to-earnings ratio of 18.77, a price-to-earnings-growth ratio of 1.39 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s payout ratio is 12.11%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research analyst reports. Morgan Stanley cut their price objective on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. KeyCorp boosted their price objective on shares of HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. UBS Group lifted their price target on shares of HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Truist Financial set a $460.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 14th. Finally, Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $437.19.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.